Avanza Fonder AB lessened its stake in shares of The Progressive Co. (NYSE:PGR - Free Report) by 10.8% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 42,682 shares of the insurance provider's stock after selling 5,194 shares during the period. Avanza Fonder AB's holdings in Progressive were worth $12,003,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the stock. Sycomore Asset Management increased its position in shares of Progressive by 42.8% during the fourth quarter. Sycomore Asset Management now owns 51,770 shares of the insurance provider's stock worth $13,066,000 after acquiring an additional 15,512 shares in the last quarter. Vivid Wealth Management LLC bought a new stake in shares of Progressive during the fourth quarter worth about $2,143,000. Van ECK Associates Corp increased its position in shares of Progressive by 3.4% during the fourth quarter. Van ECK Associates Corp now owns 16,199 shares of the insurance provider's stock worth $3,881,000 after acquiring an additional 527 shares in the last quarter. Allstate Corp bought a new stake in shares of Progressive during the fourth quarter worth about $4,205,000. Finally, Baird Financial Group Inc. increased its position in shares of Progressive by 3.1% during the fourth quarter. Baird Financial Group Inc. now owns 3,667,903 shares of the insurance provider's stock worth $878,866,000 after acquiring an additional 111,659 shares in the last quarter. Institutional investors and hedge funds own 85.34% of the company's stock.
Insider Buying and Selling
In related news, insider Steven Broz sold 1,267 shares of the firm's stock in a transaction that occurred on Friday, May 23rd. The shares were sold at an average price of $277.81, for a total value of $351,985.27. Following the completion of the transaction, the insider now directly owns 28,888 shares of the company's stock, valued at approximately $8,025,375.28. This trade represents a 4.20% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO John P. Sauerland sold 10,000 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $268.59, for a total transaction of $2,685,900.00. Following the completion of the transaction, the chief financial officer now directly owns 248,024 shares of the company's stock, valued at approximately $66,616,766.16. This trade represents a 3.88% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,755 shares of company stock valued at $10,367,074. Company insiders own 0.34% of the company's stock.
Progressive Stock Performance
Shares of Progressive stock traded down $0.84 on Friday, reaching $267.58. 3,152,193 shares of the company traded hands, compared to its average volume of 2,680,269. The Progressive Co. has a 52 week low of $203.39 and a 52 week high of $292.99. The company has a 50 day moving average of $275.93 and a 200 day moving average of $264.55. The firm has a market capitalization of $156.86 billion, a PE ratio of 18.58, a PEG ratio of 1.70 and a beta of 0.40. The company has a debt-to-equity ratio of 0.27, a current ratio of 0.31 and a quick ratio of 0.30.
Progressive (NYSE:PGR - Get Free Report) last released its earnings results on Wednesday, April 16th. The insurance provider reported $4.65 earnings per share for the quarter, beating analysts' consensus estimates of $4.28 by $0.37. The firm had revenue of $22.21 billion during the quarter, compared to the consensus estimate of $21.87 billion. Progressive had a net margin of 11.25% and a return on equity of 33.79%. Equities analysts forecast that The Progressive Co. will post 14.68 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on the stock. Barclays upped their price objective on shares of Progressive from $285.00 to $297.00 and gave the stock an "equal weight" rating in a research report on Friday, April 11th. JPMorgan Chase & Co. upped their price objective on shares of Progressive from $267.00 to $287.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Bank of America raised shares of Progressive from a "neutral" rating to a "buy" rating and set a $312.00 price objective for the company in a research report on Monday, April 28th. Wells Fargo & Company upped their price objective on shares of Progressive from $324.00 to $328.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 7th. Finally, Roth Mkm upped their price objective on shares of Progressive from $290.00 to $315.00 and gave the stock a "buy" rating in a research report on Tuesday, February 25th. Eight equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $288.59.
Get Our Latest Report on PGR
Progressive Company Profile
(
Free Report)
The Progressive Corporation, an insurance holding company, provides personal and commercial auto, personal residential and commercial property, business related general liability, and other specialty property-casualty insurance products and related services in the United States. It operates in three segments: Personal Lines, Commercial Lines, and Property.
Featured Stories

Before you consider Progressive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Progressive wasn't on the list.
While Progressive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.